Health
Merck ends COVID vaccine program, cites inferior immune responses – Reuters
Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental…
(Reuters) – Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental oral antiviral expected by the end of March.
FILE PHOTO: A scientist is seen in the Themis Bioscience laboratory in Vienna, Austria, in this undated handout photo. Themis Bioscience/Martin Wacht/Handout via REUTERS /File Photo
Merck was late to join the race to develop a vaccine to protect against the coronavirus, which…
-
Noosa News19 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News18 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General22 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General22 hours agoDisloyal far-left breakaways are coming for Labor